(OKLO) Oklo - NYSE

Sector: Utilities | Industry: Utilities - Independent Power Producers | Exchange: NYSE (USA) | Market Cap: 10.003m USD | Total Return: -7.2% in 12m

Nuclear Reactors, Fuel Recycling, Radioisotopes
Total Rating 14
Safety 59
Buy Signal -0.57
Utilities - Independent Power Producers
Industry Rotation: +0.7
Market Cap: 10.0B
Avg Turnover: 835M
Risk 3d forecast
Volatility100.0%
VaR 5th Pctl15.0%
VaR vs Median-9.51%
Reward TTM
Sharpe Ratio0.41
Rel. Str. IBD11.6
Rel. Str. Peer Group5.1
Character TTM
Beta3.593
Beta Downside3.450
Hurst Exponent0.484
Drawdowns 3y
Max DD73.83%
CAGR/Max DD1.08
CAGR/Mean DD2.85

Warnings

Share dilution 23.2% YoY

High Debt while negative Cash Flow

Tailwinds

No distinct edge detected

Description: OKLO Oklo

Oklo Inc. is a Santa Clara-based energy company specializing in advanced fission technology through its modular Aurora powerhouse design. These plants are engineered to provide carbon-free electricity with capacities ranging from 15 to 75 megawatts, targeting high-demand sectors such as data centers and industrial facilities.

The company operates an integrated business model that includes nuclear fuel recycling and the production of medical radioisotopes. By converting decommissioned nuclear waste into usable fuel, Oklo aims to reduce environmental impact and secure its own supply chain within the burgeoning small modular reactor (SMR) market. Unlike traditional large-scale reactors, SMRs utilize factory-based fabrication to lower capital costs and shorten construction timelines.

For more granular data on the companys financial health, consider reviewing the metrics available on ValueRay.

Headlines to Watch Out For
  • NRC licensing approval timeline for Aurora powerhouse commercial deployment
  • Data center demand drives long-term power purchase agreement growth
  • Fuel recycling technology commercialization reduces uranium procurement costs
  • Federal subsidies for advanced nuclear energy impact project profitability
  • Capital expenditure requirements for first-of-a-kind reactor construction efficiency
Piotroski VR-10 (Strict) 0.0
Net Income: error (cannot be calculated; needs Net Income TTM and Revenue TTM)
FCF/TA: -0.06 > 0.02 and ΔFCF/TA 8.86 > 1.0
NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev)
CFO/TA -0.03 > 3% & CFO -87.8m > Net Income -128.9m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 59.93 > 1.5 & < 3
Outstanding Shares: last quarter (170.3m) vs 12m ago 23.33% < -2%
Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin)
Asset Turnover: 0.0% > 50% (prev 0.0%; Δ 0.0% > 0%)
Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM)
Altman Z'' 10.00
A: 0.81 (Total Current Assets 2.23b - Total Current Liabilities 37.1m) / Total Assets 2.70b
B: -0.10 (Retained Earnings -273.8m / Total Assets 2.70b)
C: -0.08 (EBIT TTM -125.9m / Avg Total Assets 1.50b)
D: 40.67 (Book Value of Equity 2.64b / Total Liabilities 64.9m)
Altman-Z'' = 47.12 = AAA
What is the price of OKLO shares?

As of June 17, 2026, the stock is trading at USD 60.74 with a total of 9,533,837 shares traded.
Over the past week, the price has changed by +3.05%, over one month by -2.43%, over three months by +1.76% and over the past year by -7.20%.

Is OKLO a buy, sell or hold?

Oklo has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy OKLO.

  • StrongBuy: 4
  • Buy: 2
  • Hold: 3
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the OKLO price?
Analysts Target Price 88.6 45.9%
Oklo (OKLO) - Fundamental Data Overview as of 14 June 2026
Market Cap USD = 10.0b (10.0b USD * 1.0 USD.USD)
P/B = 3.7909
Revenue TTM = 0.0 USD
EBIT TTM = -125.9m USD
EBITDA TTM = -125.3m USD
Long Term Debt = 1.59m USD (estimated: total debt 2.62m - short term 1.03m)
Short Term Debt = 1.03m USD (from shortTermDebt, last quarter)
Debt = 2.62m USD (from shortLongTermDebtTotal, last quarter) (leases 2.62m already included)
Net Debt = -2.21b USD (calculated: Debt 2.62m - CCE 2.21b)
Enterprise Value = 7.80b USD (10.0b + Debt 2.62m - CCE 2.21b)
 Interest Coverage Ratio = unknown (Ebit TTM -125.9m / Interest Expense TTM 0.0)
 EV/FCF = -50.80x (Enterprise Value 7.80b / FCF TTM -153.5m)
FCF Yield = -1.97% (FCF TTM -153.5m / Enterprise Value 7.80b)
 FCF Margin = unknown (Revenue TTM is 0 or missing)
 Net Margin = unknown
 Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 522k) / Revenue TTM)
 Tobins Q-Ratio = 2.88 (Enterprise Value 7.80b / Total Assets 2.70b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 2.62m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -99.4m (EBIT -125.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 59.93 (Total Current Assets 2.23b / Total Current Liabilities 37.1m)
Debt / Equity = 0.00 (Debt 2.62m / totalStockholderEquity, last quarter 2.64b)
 Debt / EBITDA = 17.60 (negative EBITDA) (Net Debt -2.21b / EBITDA -125.3m)
 Debt / FCF = 14.37 (negative FCF - burning cash) (Net Debt -2.21b / FCF TTM -153.5m)
 Total Stockholder Equity = 1.50b (last 4 quarters mean from totalStockholderEquity)
RoA = -8.58% (Net Income -128.9m / Total Assets 2.70b)
RoE = -8.57% (Net Income TTM -128.9m / Total Stockholder Equity 1.50b)
RoCE = -8.36% (EBIT -125.9m / Capital Employed (Equity 1.50b + L.T.Debt 1.59m))
 RoIC = -3.73% (negative operating profit) (NOPAT -99.4m / Invested Capital 2.67b)
 WACC = 18.62% (E(10.0b)/V(10.0b) * Re(18.62%) + D(2.62m)/V(10.0b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 18.62% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 86.67 | Cagr: 49.29%
 [DCF] Fair Price = unknown (Cash Flow -153.5m)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.06 | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: N/A | SUE: 0.0 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.15 | Chg30d=N/A | Revisions=+20% | Analysts=10
EPS next Quarter (2026-09-30): EPS=-0.17 | Chg30d=N/A | Revisions=+20% | Analysts=10
EPS current Year (2026-12-31): EPS=-0.69 | Chg30d=N/A | Revisions=+20% | GrowthEPS=+4.3% | GrowthRev=+0.0%
EPS next Year (2027-12-31): EPS=-0.84 | Chg30d=N/A | Revisions=+27% | GrowthEPS=-22.2% | GrowthRev=+337.9%
[Analyst] Revisions Ratio: +27%